Charles River partners with Magellan Stem Cells on cell therapy
The partnership focuses on biologics quality control as well as viral and release testing under cGMP standards.
Drug Development
Pfizer partners with Enodia Therapeutics in $500m drug deal
China’s NMPA clears Foresee’s Camcevi 42 mg for prostate cancer
Southern Research secures NIH funding for drug testing hub
FDA approves Asahi Kasei’s Hovilpri for refractory HSV
Perceptive, Nucleus partner to support radiopharmaceutical development
Bio-Techne opens GMP small molecule facility in Bristol, UK
Biohaven partners with Ono in $100m IgG degrader deal
